iX Biopharma Ltd. announced that it has allotted and issued 32,000 new ordinary shares on Apr, 28 2026 following the exercise of warrants at 0.06 Singapore dollars per share.

The issuance raises the company’s total share count to 1,050,752,024 from 1,050,720,024.

The new shares rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on or around Apr, 30 2026.

Following this exercise, 19,992,579 warrants—34.76% of the total originally issued—have been exercised, leaving 37,516,900 warrants outstanding. The remaining warrants carry an exercise price of 0.06 Singapore dollars and will expire on Jul, 18 2026.